Newsletter

Pol. Merkur. Lek (Pol. Med. J.), 2014, XXXVII/218: 124-127 Maximize

Pol. Merkur. Lek (Pol. Med. J.), 2014, XXXVII/218: 124-127

Title: Psoriasis as metabolic and cardiovascular risk factor

/ Authors: Tupikowska M., Zdrojowy-Wełna A., Maj J.

More details

13/218

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Psoriasis as metabolic and cardiovascular risk factor


Tupikowska M.1, Zdrojowy-Wełna A.1, Maj J.2

Medical University of Wrocław, Poland: 1Chair and Department of Dermatology, Venerology and Allergology; 2Chair and Department of Endocrinology, Diabetology and Isotop Therapy

Psoriasis is a chronic, inflammatory and proliferative disease which has a tendency to recur. Metabolic disturbances occur more often in patients with psoriasis in comparison to the general population. Due to the systemic inflammation and metabolic disturbances in psoriasis the risk of cardiovascular diseases is significantly higher. The data on higher cardiovascular risk which accompanies psoriasis suggest that every patient with psoriasis or psoriatic arthritis should be screened for metabolic disturbances. Patients with psoriasis should be under special care of general practitioner in order to prevent, diagnose and treat metabolic disturbances early.

Key words: psoriasis, metabolic syndrome, cardiovascular disease

Pol. Merk. Lek., 2014, XXXVII, 218, 124